Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04401709
What this trial is testing

Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center 490
Large-scale testing (Phase 3)Study completedNCT04185363
What this trial is testing

An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)

Who this might be right for
Progressive Familial Intrahepatic Cholestasis (PFIC)
Mirum Pharmaceuticals, Inc. 84
Not applicableUnknownNCT04661319
What this trial is testing

Impact of Video Editing Training for Novice Trainees in Laparoscopic Cholecystectomy

Who this might be right for
Gallstone; Colic
Seoul St. Mary's Hospital 90
Very early researchStudy completedNCT03395028
What this trial is testing

GCSF Adjunct Therapy for Biliary Atresia

Who this might be right for
Biliary Atresia
Holterman, Ai-Xuan, M.D. 6
Testing effectiveness (Phase 2)WithdrawnNCT02965911
What this trial is testing

Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

Who this might be right for
Primary Biliary Cirrhosis
Beijing 302 Hospital
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Ended earlyNCT02325492
What this trial is testing

Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study

Who this might be right for
Gallstones
Galmed Pharmaceuticals Ltd 10
Not applicableUnknownNCT02972944
What this trial is testing

Laparoscopic Cholecystectomy or Conservative Treatment in the Acute Cholecystitis of Elderly Patients

Who this might be right for
Cholecystitis, Acute
Kuopio University Hospital 200
Not applicableStudy completedNCT00530998
What this trial is testing

Minimally Invasive Surgery: Using Natural Orfices

Who this might be right for
AppendicitisCholelithiasisGallstones
University of California, San Diego 120
Large-scale testing (Phase 3)Looking for participantsNCT06755151
What this trial is testing

Fenofibrate in Primary Biliary Cholangitis: a Real World Study

Who this might be right for
Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases 300
Large-scale testing (Phase 3)Ended earlyNCT06121375
What this trial is testing

Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy

Who this might be right for
Biliary Atresia
Intercept Pharmaceuticals 28
Not applicableStudy completedNCT02692911
What this trial is testing

Chile Biliary Longitudinal Study

Who this might be right for
Gallbladder CancerNutritional and Metabolic Diseases
National Cancer Institute (NCI) 4,749
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Looking for participantsNCT06548412
What this trial is testing

CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers

Who this might be right for
Metastatic Biliary Tract Cancer
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07654530
What this trial is testing

Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.

Who this might be right for
Biliary Tract Cancers (BTC)
Tianjin Medical University Cancer Institute and Hospital 107
Testing effectiveness (Phase 2)Study completedNCT06111872
What this trial is testing

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

Who this might be right for
CholangitisPancreatic CancerCholedocholithiasis+1 more
National University of Malaysia 90
Not applicableUnknownNCT04542512
What this trial is testing

Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.

Who this might be right for
Cholecystitis, AcuteCholecystitis; GangrenousCholecystitis Suppurative+1 more
Poissy-Saint Germain Hospital 800
Not applicableLooking for participantsNCT06699030
What this trial is testing

A Strategy for Gallstone Expulsion Through Dietary Therapy

Who this might be right for
Gallbladder Stone
Hepatopancreatobiliary Surgery Institute of Gansu Province 100
Testing effectiveness (Phase 2)Study completedNCT01815307
What this trial is testing

Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group 70
Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Next Page